Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alfons Grunenberg is active.

Publication


Featured researches published by Alfons Grunenberg.


International Journal of Pharmaceutics | 1995

Polymorphism in binary mixtures, as exemplified by nimodipine

Alfons Grunenberg; B. Keil; J.-O. Henck

Abstract The results of studies on nimodipine in the solid state demonstrate that the compound occurs in two polymorphic forms. Modification I melts at + 124°C and crystallizes as the racemic compound. Modification II (m.p. + 116°C) is a conglomerate. The two polymorphs have been characterized by means of differential scanning calorimetry, infrared, Raman, and 13C-NMR spectroscopy, X-ray powder diffractometry, X-ray structure analysis, pycnometry, and solubility measurements. The thermodynamic relationships are illustrated in a semi-schematic energy/temperature diagram, which gives information about the relative stability and physical properties of the two modifications. Modification II is the stable form between absolute zero and about + 90°C. The melting characteristics of the two polymorphs are illustrated by the phase diagram. Modification I is yellow. Modification II is almost white. The differences in colour are discussed with reference to the results of X-ray structure analyses and the UV-Vis spectra.


Archive | 1996

Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification

Alfons Grunenberg; Patrick Bosche


Archive | 2003

Medicaments containing vardenafil hydrochloride trihydrate

Peter Serno; Alfons Grunenberg; Andreas Ohm; Rainer Bellinghausen; Eimer Vollers; Jan-Olav Henck


Pharmazie in Unserer Zeit | 1997

Polymorphie und Thermische Analyse pharmazeutischer Wirkstoffe

Alfons Grunenberg


Archive | 1996

Crystalline hydrochloride of (R)-(-)-2-[N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-butyl]-aminomethyl]-chroman

Alfons Grunenberg; Oliver Dr Brehm; Michael Conrad; Dietrich Seidel


Archive | 2005

Thermodynamically stable form of a tosylate salt

Alfons Grunenberg; Jana Lenz


Archive | 2007

4-[4-(amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate

Alfons Grunenberg; Juergen Stiehl; Katharina Tenbieg; Birgit Keil


Archive | 2007

4-[4-({[4-chloro-3-(trifluorométhyl)phényl)]carbamoyl}amino)-3-fluorophénoxy]-n-méthylpyridine-2-carboxamide monohydraté

Alfons Grunenberg; Juergen Stiehl; Katharina Tenbieg; Birgit Keil


Archive | 1996

Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it

Alfons Grunenberg; Patrick Bosche


Archive | 2014

FORMS OF METHYL {4,6-DIAMINO-2-[1 (2-FLUOROBENZYL)-1H-PYRAZOLO[3-4-B]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE

Birgit Keil; Franz-Josef Mais; Winfried Joentgen; Alfons Grunenberg

Collaboration


Dive into the Alfons Grunenberg's collaboration.

Researchain Logo
Decentralizing Knowledge